529 related articles for article (PubMed ID: 8295346)
1. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
[TBL] [Abstract][Full Text] [Related]
2. [Differentiation between fibrin degradation products and fibrinogen degradation products by using newly developed ELISAs].
Isogai N; Yamagishi T; Kaku M; Matsumoto K; Yamamoto Y; Kuroso K; Arai M; Yorifuji H; Fukutake K; Fujimaki M
Rinsho Byori; 1991 Jul; 39(7):753-7. PubMed ID: 1920869
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.
Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A
Thromb Haemost; 1990 Jun; 63(3):340-4. PubMed ID: 2402738
[TBL] [Abstract][Full Text] [Related]
4. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
[TBL] [Abstract][Full Text] [Related]
5. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
Horan JT; Francis CW
Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
[TBL] [Abstract][Full Text] [Related]
7. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
[TBL] [Abstract][Full Text] [Related]
9. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
10. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
11. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
Koppert PW; Kuipers W; Hoegee-de Nobel B; Brommer EJ; Koopman J; Nieuwenhuizen W
Thromb Haemost; 1987 Feb; 57(1):25-8. PubMed ID: 2438796
[TBL] [Abstract][Full Text] [Related]
12. Degradation of cross-linked fibrin by leukocyte elastase as alternative pathway for plasmin-mediated fibrinolysis in sepsis-induced disseminated intravascular coagulation.
Madoiwa S; Tanaka H; Nagahama Y; Dokai M; Kashiwakura Y; Ishiwata A; Sakata A; Yasumoto A; Ohmori T; Mimuro J; Sakata Y
Thromb Res; 2011 Apr; 127(4):349-55. PubMed ID: 21236472
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
Kim S; Wadhwa NK; Kant KS; Pollak VE; Glas-Greenwalt P; Weiss MA; Hong CG
Q J Med; 1988 Nov; 69(259):879-905. PubMed ID: 3078212
[TBL] [Abstract][Full Text] [Related]
14. [Studies on the fragments of FDP in 4 patients with DIC].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Oct; 40(10):1089-95. PubMed ID: 1307614
[TBL] [Abstract][Full Text] [Related]
15. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
[TBL] [Abstract][Full Text] [Related]
16. Problems of diagnosis of disseminated intravascular coagulation (DIC).
Bowie EJ; Owen CA
Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):325-7. PubMed ID: 515796
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of clinical usefulness of a rapid quantitative measurement of D dimer (cross-linked fibrin degradation products)].
Takahashi H; Wada K; Takizawa S; Sakurai G; Hanano M; Niwano H; Tatewaki W; Shibata A
Rinsho Ketsueki; 1991 Dec; 32(12):1533-9. PubMed ID: 1779452
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
[TBL] [Abstract][Full Text] [Related]
19. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
[TBL] [Abstract][Full Text] [Related]
20. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Mombelli G; Monotti R; Haeberli A; Straub PW
Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
